The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China

Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults

(2013) Shujun Zhang et al.   JOURNAL OF MEDICAL VIROLOGY

Novel Adenoviruses in Wild Primates: a High Level of Genetic Diversity and Evidence of Zoonotic Transmissions

(2011) D. Wevers et al.   JOURNAL OF VIROLOGY

Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China

(2011) Caijun Sun et al.   VACCINE

Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys

(2010) Caijun Sun et al.   JOURNAL OF INFECTION

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species ofAdenoviridae

(2010) H. Chen et al.   JOURNAL OF VIROLOGY

Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys

(2010) Jonatan Ersching et al.   VIROLOGY

Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel

(2009) M P Broderick et al.   INTERNATIONAL JOURNAL OF OBESITY

Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses

(2009) Roberto Calcedo et al.   JOURNAL OF INFECTIOUS DISEASES

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans

(2009) Kara L O'Brien et al.   NATURE MEDICINE

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

(2008) Jinyan Liu et al.   NATURE